BrightSpring Health Services (NASDAQ:BTSG) Posts Earnings Results, Beats Expectations By $0.05 EPS

BrightSpring Health Services (NASDAQ:BTSG) issued its quarterly earnings results on Friday. The company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.05, FiscalAI reports. The company had revenue of $3.87 billion during the quarter, compared to the consensus estimate of $3.66 billion. BrightSpring Health Services had a net margin of 2.27% and a return on equity of 14.63%. The firm’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.22 EPS.

Here are the key takeaways from BrightSpring Health Services’ conference call:

• BrightSpring reported a strong second quarter, with revenue of $3.9 billion, up 23% year over year, and adjusted EBITDA of $206 million, up 44%, while EBITDA margin expanded 80 basis points to 5.3%.
• Specialty and infusion pharmacy revenue increased 30%, supported by 31% script growth and continued momentum in limited-distribution drugs; the company added two ultranarrow-network drugs, bringing its LDD portfolio to 155.
• Provider Services grew 30%, led by home health revenue growth of 51% and contributions from the Amedisys and LHC branches. BrightSpring raised its expected 2026 EBITDA contribution from those acquired assets to approximately $35 million.
• The Inflation Reduction Act is expected to reduce 2026 home and community pharmacy revenue by approximately $200 million, including about $45 million in each remaining quarter; management estimates the 2027 impact will be roughly half as large.
• BrightSpring reduced leverage to 2.15x, repaid approximately $300 million of term debt, refinanced at a 50-basis-point lower spread, and received credit-rating upgrades. Management now expects about $600 million of 2026 operating cash flow and year-end leverage below 2x before acquisitions, supporting additional M&A flexibility.

BrightSpring Health Services Trading Down 18.0%

Shares of NASDAQ:BTSG traded down $13.12 during mid-day trading on Friday, reaching $59.76. 6,248,290 shares of the company’s stock were exchanged, compared to its average volume of 3,014,156. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.38 and a current ratio of 1.74. BrightSpring Health Services has a twelve month low of $19.01 and a twelve month high of $73.75. The firm has a market capitalization of $11.79 billion, a price-to-earnings ratio of 42.38, a PEG ratio of 0.88 and a beta of 1.79. The business’s fifty day moving average price is $66.35 and its 200-day moving average price is $51.80.

BrightSpring Health Services News Summary

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: BrightSpring reported second-quarter adjusted earnings of $0.45 per share, above analyst estimates of $0.40 and up from $0.22 a year earlier. Revenue rose 23% year over year to $3.87 billion, exceeding the $3.66 billion consensus estimate. BrightSpring Health Services Q2 earnings report
• Positive Sentiment: The company increased its full-year 2026 revenue guidance to $15.1 billion-$15.4 billion, with the low end roughly in line with consensus and the upper end above expectations. Management also projected adjusted EBITDA of $820 million-$845 million and is targeting leverage below 2x, which could support debt reduction and financial flexibility. BrightSpring Q2 2026 results and guidance
• Neutral Sentiment: The earnings call and analyst coverage emphasized that both revenue and profit surpassed expectations, but the company did not provide a notable full-year EPS guidance figure in the available reports. BrightSpring Q2 2026 earnings call transcript
• Negative Sentiment: The revenue outlook appears only modestly ahead of Wall Street expectations, which may have disappointed investors seeking a larger guidance increase. With BTSG trading at a relatively elevated earnings multiple after reaching a 52-week high, the strong quarter may have been insufficient to meet elevated expectations, triggering selling despite the earnings and revenue beats.

Insiders Place Their Bets

In related news, insider Lisa A. Nalley sold 35,000 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of $58.75, for a total transaction of $2,056,250.00. Following the completion of the transaction, the insider directly owned 131,948 shares of the company’s stock, valued at $7,751,945. This trade represents a 20.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jon B. Rousseau sold 130,000 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of $58.75, for a total value of $7,637,500.00. Following the transaction, the insider directly owned 1,194,503 shares of the company’s stock, valued at approximately $70,177,051.25. This represents a 9.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 2.80% of the company’s stock.

Hedge Funds Weigh In On BrightSpring Health Services

A number of hedge funds have recently made changes to their positions in BTSG. AQR Capital Management LLC acquired a new position in shares of BrightSpring Health Services in the first quarter worth approximately $276,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in BrightSpring Health Services by 5.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 32,429 shares of the company’s stock worth $587,000 after purchasing an additional 1,780 shares during the last quarter. Millennium Management LLC raised its holdings in BrightSpring Health Services by 0.3% during the 1st quarter. Millennium Management LLC now owns 577,885 shares of the company’s stock worth $10,454,000 after purchasing an additional 1,967 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of BrightSpring Health Services by 11.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 147,280 shares of the company’s stock worth $2,664,000 after purchasing an additional 14,586 shares during the period. Finally, Prudential Financial Inc. acquired a new position in shares of BrightSpring Health Services in the 2nd quarter worth approximately $351,000.

Analysts Set New Price Targets

Several research analysts have commented on BTSG shares. TD Cowen boosted their price objective on shares of BrightSpring Health Services from $65.00 to $81.00 and gave the company a “buy” rating in a research report on Thursday, June 18th. BTIG Research boosted their price target on BrightSpring Health Services from $65.00 to $90.00 and gave the stock a “buy” rating in a report on Monday, June 22nd. Guggenheim began coverage on BrightSpring Health Services in a research report on Monday, July 13th. They set a “buy” rating and a $81.00 price objective for the company. BMO Capital Markets set a $70.00 price objective on BrightSpring Health Services in a research note on Thursday, May 21st. Finally, KeyCorp lifted their target price on BrightSpring Health Services from $60.00 to $80.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, BrightSpring Health Services has a consensus rating of “Buy” and an average target price of $70.12.

BrightSpring Health Services Company Profile

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.